728 research outputs found

    Beta-delayed-neutron studies of 135,136^{135,136}Sb and 140^{140}I performed with trapped ions

    Get PDF
    Beta-delayed-neutron (β\betan) spectroscopy was performed using the Beta-decay Paul Trap and an array of radiation detectors. The β\betan branching ratios and energy spectra for 135,136^{135,136}Sb and 140^{140}I were obtained by measuring the time of flight of recoil ions emerging from the trapped ion cloud. These nuclei are located at the edge of an isotopic region identified as having β\betan branching ratios that impact the r-process abundance pattern around the A~130 peak. For 135,136^{135,136}Sb and 140^{140}I, β\betan branching ratios of 14.6(11)%, 17.6(28)%, and 7.6(28)% were determined, respectively. The β\betan energy spectra obtained for 135^{135}Sb and 140^{140}I are compared with results from direct neutron measurements, and the β\betan energy spectrum for 136^{136}Sb has been measured for the first time

    The use of cosmic-ray muons in the energy calibration of the Beta-decay Paul Trap silicon-detector array

    Get PDF
    This article presents an approach to calibrate the energy response of double-sided silicon strip detectors (DSSDs) for low-energy nuclear-science experiments by utilizing cosmic-ray muons. For the 1-mm-thick detectors used with the Beta-decay Paul Trap, the minimum-ionizing peak from these muons provides a stable and time-independent in situ calibration point at around 300 keV, which supplements the calibration data obtained above 3 MeV from α sources. The muon-data calibration is achieved by comparing experimental spectra with detailed Monte Carlo simulations performed using GEANT4 and CRY codes. This additional information constrains the calibration at lower energies, resulting in improvements in quality and accuracy

    β-delayed neutron emission studies of i 137,138 and Cs 144,145 performed with trapped ions

    Get PDF
    A detailed study of the β-delayed neutron emission properties of I137,138 and Cs144,145 has been performed by confining ions in the Beta-decay Paul Trap. The daughter ions following β decay emerge from the trapped-ion cloud with negligible scattering allowing reconstruction of the recoil-ion energy from the time of flight. From this information, the neutron-emission branching ratios and neutron-energy spectra were deduced. The results for the I137 and Cs144,145 decays are in agreement with previous results performed using direct neutron-detection techniques. In the case of I138, a branching ratio of 6.18(50)% is obtained, yielding a value consistent with the more recent results, which are a factor of two larger than measurements made prior to 1978

    Prediction of higher mortality reduction for the UK Breast Screening Frequency Trial: A model-based approach on screening intervals

    Get PDF
    Background: The optimal interval between two consecutive mammograms is uncertain. The UK Frequency Trial did not show a significant difference in breast cancer mortality between screening every year (study group) and screening every 3 years (control group). In this study, the trial is simulated in order to gain insight into the results of the trial and to predict the effect of different screening intervals on breast cancer mortality. Methods: UK incidence, life tables and information from the trial were used in the microsimulation model MISCAN-Fadia to simulate the trial and predict the number of breast ca

    Value of flow cytometry for MRD-based relapse prediction in B-cell precursor ALL in a multicenter setting

    Get PDF
    PCR of TCR/Ig gene rearrangements is considered the method of choice for minimal residual disease (MRD) quantification in BCP-ALL, but flow cytometry analysis of leukemia-associated immunophenotypes (FCM-MRD) is faster and biologically more informative. FCM-MRD performed in 18 laboratories across seven countries was used for risk stratification of 1487 patients with BCP-ALL enrolled in the NOPHO ALL2008 protocol. When no informative FCM-marker was available, risk stratification was based on real-time quantitative PCR. An informative FCM-marker was found in 96.2% and only two patients (0.14%) had non-informative FCM and non-informative PCR-markers. The overall 5-year event-free survival was 86.1% with a cumulative incidence of relapse (CIR5y) of 9.5%. FCM-MRD levels on days 15 (HzR 4.0, p 10(-4) associated with a CIR5y = 22.1%. In conclusion, FCM-MRD performed in a multicenter setting is a clinically useful method for MRD-based treatment stratification in BCP-ALL.Peer reviewe
    • …
    corecore